Massive transfusion protocols for patients with substantial hemorrhage.
about
Massive blood transfusion during hospitalization for delivery in New York State, 1998-2007.Effect of a fixed-ratio (1:1:1) transfusion protocol versus laboratory-results-guided transfusion in patients with severe trauma: a randomized feasibility trialAn emergency department thawed plasma protocol for severely injured patientsCurrent concepts, which effect outcome following major hemorrhage.Comparison of in vitro responses to fresh whole blood and reconstituted whole blood after collagen stimulation.Trauma patients at risk for massive transfusion: the role of scoring systems and the impact of early identification on patient outcomes.Use of point-of-care testing for plasma therapy.Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy.Traumatic coagulopathy--part 2: Resuscitative strategies.Blood component transfusion and wastage rates in the setting of massive transfusion in three regional trauma centers.A possible new paradigm? A survey-based assessment of the use of thawed group A plasma for trauma resuscitation in the United States.Economic aspects of intraoperative coagulation management targeting higher fibrinogen concentrations during major craniosynostosis surgery.A national common massive transfusion protocol (MTP) is a feasible and advantageous option for centralized blood services and hospitals.Functional capacity of reconstituted blood in 1:1:1 versus 3:1:1 ratios: a thrombelastometry study.Blood ordering from the operating room: turnaround time as a quality indicator.Experience with a massive transfusion protocol in the management of massive haemorrhage.The feasibility of civilian prehospital trauma teams carrying and administering packed red blood cells.Patient blood management: use of topical hemostatic and sealant agents.Comparison of the impact of applications of Targeted Transfusion Protocol and Massive Transfusion Protocol in trauma patients.Postauthorization safety study of Clottafact® , a triply secured fibrinogen concentrate in acquired fibrinogen deficiency: a prospective observational study.Characteristics and Outcomes of Blood Product Transfusion During Critical Care Transport.Prehospital Transfusion of Plasma and Red Blood Cells in Trauma Patients.
P2860
Q35990798-ABBFFEA3-8158-48DE-9C5B-6C45DC5DC9EBQ37142033-982ACDAD-F3DA-4AAE-95A0-C8C8CB6B025BQ37238438-7F2609A4-A62D-4568-8B7B-7A98A8EB00B1Q37550995-466BB777-C2AF-4E25-B86C-8879522274E6Q37588938-AC30915D-35B0-408D-A616-E07E6FD0762EQ37999887-FAD64BC2-EBEE-446F-A8C9-EC24AFA815DBQ38009421-77633D51-D459-49DB-ADCC-C2FFD05D1B88Q38151867-78C8E571-5B3D-43FB-94F6-6321BAAD7D3DQ38176103-0C27350B-5FF3-4BC3-8300-5BD90FFD354DQ39256152-EC70C4AC-BFC0-4A24-B8E4-278945BE8D0AQ40307063-65663BDC-7454-4652-B49F-A77389AA28AAQ40441737-2EC22F60-3509-4D32-A5FE-A08E8CBBFF8CQ40732882-BE9B96A9-0895-45BD-9E95-127800485D80Q43108387-6AD7D450-714E-4875-9D4B-62848D38A116Q44267859-01932792-0925-4C64-98D9-1F7999F85AE8Q44487813-2B66F2AB-3ACB-402A-B221-2EAC4B0D2559Q45283508-C5850762-DDA5-4C89-8554-FDB95C7D657BQ46375927-995EDD83-2831-48DD-9749-020F1A9FD231Q47145839-25DA23A5-4380-41AF-B27F-EF1174D26BB7Q47313093-0C2E79B9-10C8-4F5F-9EF5-A36B66CCD29CQ50232082-D001DC2D-7E40-451B-A8CE-45EAD3574375Q50468612-0C29A30D-A921-4740-98D5-8C9F60789F7F
P2860
Massive transfusion protocols for patients with substantial hemorrhage.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Massive transfusion protocols for patients with substantial hemorrhage.
@ast
Massive transfusion protocols for patients with substantial hemorrhage.
@en
Massive transfusion protocols for patients with substantial hemorrhage.
@nl
type
label
Massive transfusion protocols for patients with substantial hemorrhage.
@ast
Massive transfusion protocols for patients with substantial hemorrhage.
@en
Massive transfusion protocols for patients with substantial hemorrhage.
@nl
prefLabel
Massive transfusion protocols for patients with substantial hemorrhage.
@ast
Massive transfusion protocols for patients with substantial hemorrhage.
@en
Massive transfusion protocols for patients with substantial hemorrhage.
@nl
P2093
P2860
P1476
Massive transfusion protocols for patients with substantial hemorrhage.
@en
P2093
Bryan A Cotton
Lawrence T Goodnough
Pampee P Young
P2860
P304
P356
10.1016/J.TMRV.2011.04.002
P577
2011-06-12T00:00:00Z